Raymond James Financial, Inc. vs Teladoc Health Inc — how do they compare? Raymond James Financial, Inc. trades at $158.28 (market cap $30.51B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Raymond James Financial, Inc. is far larger — about 30.2× Teladoc Health Inc's market cap, and Raymond James Financial, Inc. pays a 1.36% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Raymond James Financial, Inc. for 75 Days and Teladoc Health Inc for 39 Days on average.
| RJF | TDOC | |
|---|---|---|
Market Cap | $30.51B | $1.01B |
Volume | 1,206,253 | 4,668,477 |
Sector | Financials | Health |
52-Week High | $181.18 | $9.72 |
52-Week Low | $140.89 | $4.47 |
Typical Hold Time | 75 Days | 39 Days |
Enterprise Value | $24.37B | $1.27B |
Dividend Yield | 1.36% | — |
Signals from Pluang's Aura AI — not financial advice
Raymond James Financial (RJF) trades at $158.6, up 0.83% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company has delivered three consecutive quarterly earnings beats, with Q3 2026 EPS of $3.14 exceeding the $2.93 estimate. Revenue growth has been steady, rising from $10.9B in 2022 to $13.84B in 2025, supported by a robust net income margin of 15.37% and an ROE of 18.48%.
The outlook is balanced: analyst consensus is a 'Hold' with a $184 price target, implying 16% upside, but technical weakness and volatile cash flows from aggressive investing activities pose near-term risks. Long-term growth drivers include wealth management expansion and investment banking recovery, though rising expenses and market volatility remain headwinds.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →